265 related articles for article (PubMed ID: 24447338)
1. The phosphorylation of HIV-1 Gag by atypical protein kinase C facilitates viral infectivity by promoting Vpr incorporation into virions.
Kudoh A; Takahama S; Sawasaki T; Ode H; Yokoyama M; Okayama A; Ishikawa A; Miyakawa K; Matsunaga S; Kimura H; Sugiura W; Sato H; Hirano H; Ohno S; Yamamoto N; Ryo A
Retrovirology; 2014 Jan; 11():9. PubMed ID: 24447338
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Gag Recruits Oligomeric Vpr via Two Binding Sites in p6, but Both Mature p6 and Vpr Are Rapidly Lost upon Target Cell Entry.
Wanaguru M; Bishop KN
J Virol; 2021 Aug; 95(17):e0055421. PubMed ID: 34106747
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive mutational analysis reveals p6Gag phosphorylation to be dispensable for HIV-1 morphogenesis and replication.
Radestock B; Morales I; Rahman SA; Radau S; Glass B; Zahedi RP; Müller B; Kräusslich HG
J Virol; 2013 Jan; 87(2):724-34. PubMed ID: 23115284
[TBL] [Abstract][Full Text] [Related]
4. Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses.
Selig L; Pages JC; Tanchou V; Prévéral S; Berlioz-Torrent C; Liu LX; Erdtmann L; Darlix J; Benarous R; Benichou S
J Virol; 1999 Jan; 73(1):592-600. PubMed ID: 9847364
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.
Liu H; Wu X; Xiao H; Conway JA; Kappes JC
J Virol; 1997 Oct; 71(10):7704-10. PubMed ID: 9311854
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of Vpr into human immunodeficiency virus type 1 requires a direct interaction with the p6 domain of the p55 gag precursor.
Bachand F; Yao XJ; Hrimech M; Rougeau N; Cohen EA
J Biol Chem; 1999 Mar; 274(13):9083-91. PubMed ID: 10085158
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.
Checroune F; Yao XJ; Göttlinger HG; Bergeron D; Cohen EA
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):1-7. PubMed ID: 7648278
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.
Paxton W; Connor RI; Landau NR
J Virol; 1993 Dec; 67(12):7229-37. PubMed ID: 8230445
[TBL] [Abstract][Full Text] [Related]
9. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.
Kondo E; Mammano F; Cohen EA; Göttlinger HG
J Virol; 1995 May; 69(5):2759-64. PubMed ID: 7707498
[TBL] [Abstract][Full Text] [Related]
10. Structural studies of HIV-1 Gag p6ct and its interaction with Vpr determined by solution nuclear magnetic resonance.
Salgado GF; Marquant R; Vogel A; Alves ID; Feller SE; Morellet N; Bouaziz S
Biochemistry; 2009 Mar; 48(11):2355-67. PubMed ID: 19254034
[TBL] [Abstract][Full Text] [Related]
11. Virion-targeted viral inactivation of human immunodeficiency virus type 1 by using Vpr fusion proteins.
Kobinger GP; Borsetti A; Nie Z; Mercier J; Daniel N; Göttlinger HG; Cohen A
J Virol; 1998 Jul; 72(7):5441-8. PubMed ID: 9620999
[TBL] [Abstract][Full Text] [Related]
12. A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr.
Kondo E; Göttlinger HG
J Virol; 1996 Jan; 70(1):159-64. PubMed ID: 8523520
[TBL] [Abstract][Full Text] [Related]
13. Highly conserved serine residue 40 in HIV-1 p6 regulates capsid processing and virus core assembly.
Votteler J; Neumann L; Hahn S; Hahn F; Rauch P; Schmidt K; Studtrucker N; Solbak SM; Fossen T; Henklein P; Ott DE; Holland G; Bannert N; Schubert U
Retrovirology; 2011 Feb; 8():11. PubMed ID: 21324168
[TBL] [Abstract][Full Text] [Related]
14. A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles.
Lu YL; Bennett RP; Wills JW; Gorelick R; Ratner L
J Virol; 1995 Nov; 69(11):6873-9. PubMed ID: 7474102
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Vpr Abrogates the Effect of TSG101 Overexpression to Support Virus Release.
Chutiwitoonchai N; Siarot L; Takeda E; Shioda T; Ueda M; Aida Y
PLoS One; 2016; 11(9):e0163100. PubMed ID: 27648839
[TBL] [Abstract][Full Text] [Related]
16. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.
Huang M; Orenstein JM; Martin MA; Freed EO
J Virol; 1995 Nov; 69(11):6810-8. PubMed ID: 7474093
[TBL] [Abstract][Full Text] [Related]
17. Vpr Enhances HIV-1 Env Processing and Virion Infectivity in Macrophages by Modulating TET2-Dependent IFITM3 Expression.
Wang Q; Su L
mBio; 2019 Aug; 10(4):. PubMed ID: 31431548
[TBL] [Abstract][Full Text] [Related]
18. Perturbing HIV-1 Ribosomal Frameshifting Frequency Reveals a
Benner BE; Bruce JW; Kentala JR; Murray M; Becker JT; Garcia-Miranda P; Ahlquist P; Butcher SE; Sherer NM
J Virol; 2022 Jan; 96(1):e0134921. PubMed ID: 34643428
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect.
Yao XJ; Kobinger G; Dandache S; Rougeau N; Cohen E
Gene Ther; 1999 Sep; 6(9):1590-9. PubMed ID: 10490769
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
